Inactive

Title of Requirement: Fibrosis Markers in Kidney Disease Associated with Dementia in Women versus Men Please see attached Request for Proposal (RFP) Number : 75N95022R00004 and four (4) separate .pdf ... Title of Requirement: Fibrosis Markers in Kidney Disease Associated with Dementia in Women versus Men Please see attached Request for Proposal (RFP) Number : 75N95022R00004 and four (4) separate .pdf attachments. *RFP is amended to replace attachment 1 (package and delivery instructions). See new .pdf attached.

Inactive

Notice of Proposed Contract Action THIS IS NOT A REQUEST FOR QUOTES. This synopsis is to make available a notice of proposed contract action as required by FAR 5.201. The National Institute on Drug Ab... Notice of Proposed Contract Action THIS IS NOT A REQUEST FOR QUOTES. This synopsis is to make available a notice of proposed contract action as required by FAR 5.201. The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institute on Aging (NIA) intends to negotiate under the authority of Federal Acquisition Regulation (FAR) 6.302-1, on a noncompetitive, sole source basis with Marshall University Research Corporation, Huntington, West Virginia for the project entitled “Fibrosis Markers in Kidney Disease with Dementia in Women versus Men”. This notice of intent is not a request for competitive proposal. However, responsible sources may express their interest by submitting a capability statement or proposal. All capability statements and proposals received within fifteen days after date of publication of this synopsis will be considered by the Government. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for determining whether to conduct a competitive procurement. This effort will be for a period of twelve months beginning on or about June 20, 2022. The purpose of this project entitled “Fibrosis Markers in Kidney Disease with Dementia in Women versus Men” is to analyze the association of fibrosis markers and markers of chronic kidney disease (CKD) with cognitive function in the CKD patients and specifically in women versus men. This procurement will be conducted in accordance with FAR Part 15 and result in a single firm fixed-price contract award. The North American Industry Classification System (NAICS) code for this acquisition is 541715 – Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and the business size standard for this industry is 1,000 employees. The Request for Proposal (RFP) 75N95022R00004 and all attachments necessary to prepare a proposal will be available on SAM.gov on or about February 1, 2022, with a tentative closing date of on or about March 1, 2022.